Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 2/20 | 0.81 |
| ▸ | PTPRC | P08575 | 3/20 | 0.62 |
| ▸ | S100A4 | P26447 | 2/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | GNG2 | P59768 | 1/20 | 0.46 |
| ▸ | GNB1 | P62873 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30181077 | 0.97 | BCL2 (0.87) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| SCHEMBL12960391 | 0.97 | BCL2 (0.87) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| SCHEMBL14952682 | 0.93 | BCL2 (0.86) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| SCHEMBL14206501 | 0.90 | BCL2 (1.00) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| SCHEMBL79475 | 0.86 | BCL2 (0.60) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| SCHEMBL12031457 | 0.86 | BCL2 (0.60) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| Anthraquinone SCHEMBL4307959 | 0.86 | BCL2 (0.60) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| SCHEMBL88058 | 0.86 | BCL2 (0.60) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| SCHEMBL12449237 | 0.86 | BCL2 (0.60) | BCL2PTPRCS100A4MCL1CYP1A2 | |
| SCHEMBL29354334 | 0.86 | BCL2 (0.60) | BCL2PTPRCS100A4MCL1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310300-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | HFC PRESTIGE SERVICE GERMINY GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| EP-4171500-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | Wella Germany GmbH (DE) | 2023-05-03 | — | — | EP | disclosed |
| US-11324688-B2 | Bicomponent composition | WELLA INTERNATIONAL OPERATIONS SWI (CH) | 2022-05-10 | — | — | US | disclosed |
| US-20220054392-A1 | MULTICOMPONENT IN SITU COLORATION COMPOSITION | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2022-02-24 | — | — | US | disclosed |
| US-20220016017-A1 | COLOR COATINGS WITH DOWNSTREAM FEATURES | HFC PRESTIGE SERVICE GERMANY GMBH (DE) | 2022-01-20 | — | — | US | disclosed |
| WO-2022002983-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | HFC PRESTIGE SERVICE GERMANY GMBH (DE) | 2022-01-06 | — | — | WO | disclosed |
| EP-3890683-A1 | MULTICOMPONENT IN SITU COLORATION COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-10-13 | — | — | EP | disclosed |
| US-20210290519-A1 | MULTICOMPONENT SILICONE COMPOSITION | WELLA INT OPERATIONS SWITZERLAND SARL (CH) | 2021-09-23 | — | — | US | disclosed |
| US-20210290518-A1 | MULTICOMPONENT COMPOSITION | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2021-09-23 | — | — | US | disclosed |
| US-20210145726-A1 | BICOMPONENT COMPOSITION | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2021-05-20 | — | — | US | disclosed |
| EP-3817710-A1 | MULTICOMPONENT SILICONE COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-05-12 | — | — | EP | disclosed |
| EP-3817825-A1 | MULTICOMPONENT PUR COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-05-12 | — | — | EP | disclosed |
| EP-3787753-A1 | MULTICOMPONENT COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-03-10 | — | — | EP | disclosed |
| EP-3773922-A1 | BICOMPONENT COMPOSITION | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-02-17 | — | — | EP | disclosed |
| WO-2020114647-A1 | MULTICOMPONENT IN SITU COLORATION COMPOSITION | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2020-06-11 | — | — | WO | disclosed |
| WO-2020007510-A1 | MULTICOMPONENT PUR COMPOSITION | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2020-01-09 | — | — | WO | disclosed |
| WO-2020007511-A1 | MULTICOMPONENT SILICONE COMPOSITION | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2020-01-09 | — | — | WO | disclosed |
| WO-2019192916-A1 | BICOMPONENT COMPOSITION | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2019-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220016017-A1 | COLOR COATINGS WITH DOWNSTREAM FEATURES | KRT18, ITGA5, FLNA | BCL2 2770/4885PTPRC 1799/4885S100A4 579/4885 |
| US-20230310300-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | KRT18, MKI67, IK | BCL2 1163/4885PTPRC 361/4885S100A4 59/4885 |
| US-20210290519-A1 | MULTICOMPONENT SILICONE COMPOSITION | CUTA, CD99, PLOD3 | BCL2 2641/4885PTPRC 2527/4885S100A4 348/4885 |
| US-20220054392-A1 | MULTICOMPONENT IN SITU COLORATION COMPOSITION | KRT18, PRKDC, VIM | BCL2 3545/4885PTPRC 3307/4885S100A4 410/4885 |
| US-11324688-B2 | Bicomponent composition | KRT18, EXOSC10, EXOSC9 | BCL2 2661/4885PTPRC 1341/4885S100A4 57/4885 |
| US-20210290518-A1 | MULTICOMPONENT COMPOSITION | KRT18, INCENP, IK | BCL2 2941/4885PTPRC 833/4885S100A4 49/4885 |
| US-20210145726-A1 | BICOMPONENT COMPOSITION | KRT18, EXOSC10, EXOSC9 | BCL2 2661/4885PTPRC 1341/4885S100A4 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.